Journal of neuroimmunologyAdultFemaleHumansMaleMiddle Aged
Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial.
Mohamed Y Abdelgaied, Omar Abdelgawad, Mohamed Hamed Rashad, Mohamed H Solayman, Hend M El-Tayebi
Published: 202610.1016/j.jneuroim.2025.578852
Abstract
BACKGROUND: Neurodegeneration and inflammation can accelerate the demyelination process in multiple sclerosis (MS). We aimed to investigate the efficacy and tolerability of metformin as an add-on treatment to interferon Beta 1a (IFNβ-1a) in Egyptian…
Preview only. Read the full abstract at the source